THE EFFECT OF SMALL DOSE OF ALDOSE REDUCTASE INHIBITOR (SORBINIL) ON DIABETIC NEUROPATHY

被引：0
|
作者：
LEHTINEN, J
HYVONEN, K
KILPELAINEN, H
UUSITUPA, M
PUHAKAINEN, E
PARTANEN, J
RIEKKINEN, P
机构：
[1] UNIV KUOPIO,CENT HOSP,DEPT NEUROL,SF-70101 KUOPIO 10,FINLAND
[2] UNIV KUOPIO,CENT HOSP,DEPT MED,SF-70101 KUOPIO 10,FINLAND
[3] UNIV KUOPIO,CENT HOSP,DEPT CLIN CHEM,SF-70101 KUOPIO 10,FINLAND
来源：
ACTA NEUROLOGICA SCANDINAVICA | 1984年 / 69卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：198 / 199
页数：2
相关论文
共 50 条
  • [21] CLINICAL-EXPERIENCE WITH SORBINIL - AN ALDOSE REDUCTASE INHIBITOR
    PITTS, NE
    VREELAND, F
    SHAW, GL
    PETERSON, MJ
    MEHTA, DJ
    COLLIER, J
    GUNDERSEN, K
    METABOLISM-CLINICAL AND EXPERIMENTAL, 1986, 35 (04): : 96 - 100
  • [22] The effect of sorbinil, an aldose reductase inhibitor, on aortic function in control and streptozotocin-induced diabetic rats
    Sellers, DJ
    Chess-Williams, R
    JOURNAL OF AUTONOMIC PHARMACOLOGY, 2000, 20 (01): : 15 - 22
  • [23] EFFECT OF A NEW POTENT ALDOSE REDUCTASE INHIBITOR, TAT ON DIABETIC NEUROPATHY OF RATS
    HOTTA, N
    KAKUTA, H
    KOH, N
    SAKAKIBARA, F
    KOMORI, H
    INUKAI, S
    NAITO, S
    SAKAMOTO, N
    DIABETOLOGIA, 1992, 35 : A151 - A151
  • [24] EFFECT OF AN ALDOSE REDUCTASE INHIBITOR ON DIABETIC PERIPHERAL NEUROPATHY - PRELIMINARY-REPORT
    CULEBRAS, A
    ALIO, J
    HERRERA, JL
    LOPEZFRAILE, IP
    ARCHIVES OF NEUROLOGY, 1981, 38 (02) : 133 - 134
  • [25] DIURETIC AND NATRIURETIC EFFECTS OF SORBINIL, AN ALDOSE REDUCTASE INHIBITOR
    SPRINGATE, JE
    FELD, LG
    VANLIEW, JB
    FILDES, RD
    ACARA, MA
    PHARMACOLOGICAL RESEARCH, 1991, 23 (03) : 279 - 283
  • [26] ALDOSE REDUCTASE INHIBITION IN DIABETIC NEUROPATHY - CLINICAL AND NEUROPHYSIOLOGICAL STUDIES OF ONE YEARS TREATMENT WITH SORBINIL
    OHARE, JP
    MORGAN, MH
    ALDEN, P
    CHISSEL, S
    OBRIEN, IAD
    CORRALL, RJM
    DIABETIC MEDICINE, 1988, 5 (06) : 537 - 542
  • [27] ALDOSE REDUCTASE INHIBITION WITH SORBINIL IN SYMPTOMATIC DIABETIC NEUROPATHY - A 3 MONTH CLINICAL AND NEUROPHYSIOLOGICAL STUDY
    SCHOUTEN, JA
    CLINICAL TRIALS AND META-ANALYSIS, 1993, 28 (4-5) : 203 - 214
  • [28] KINETICS OF AN ORALLY ABSORBED ALDOSE REDUCTASE INHIBITOR, SORBINIL
    FOULDS, G
    OBRIEN, MM
    BIANCHINE, JR
    GABBAY, KH
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 1981, 30 (05) : 693 - 700
  • [29] Epalrestat, an aldose reductase inhibitor, in diabetic neuropathy: An Indian perspective
    Sharma, S. R.
    Sharma, Nalini
    ANNALS OF INDIAN ACADEMY OF NEUROLOGY, 2008, 11 (04) : 231 - 235
  • [30] Effects of epalrestat, an aldose reductase inhibitor, on diabetic neuropathy and gastroparesis
    Okamoto, H
    Nomura, M
    Nakaya, Y
    Uehara, K
    Saito, K
    Kimura, M
    Chikamori, K
    Ito, S
    INTERNAL MEDICINE, 2003, 42 (08) : 655 - 664
12345